# Centry Pharma, Inc. — Form D/A

Centry Pharma, Inc. of FORT LEE, NJ, a company, filed a Form D amendment with the SEC on 2021-10-29. The offering totals $15.3M, of which $15.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-10-29
- Form: D/A
- Accession: 0001104659-21-131756
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.3M
- Amount sold: $15.3M
- Minimum investment: $20K
- Investors: 43
- Date of first sale: 2021-05-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-406723

## Issuer

- Name: Centry Pharma, Inc.
- CIK: 0001859637
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1 BRIDGE PLAZA, FORT LEE, NJ, 07024
- Phone: (201) 614-3151

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Ron Bentsur | Director | Fort Lee, NJ |
| Kenneth Hoberman | Director | New York, NY |
| Matthew Kaplan | Director | New York, NY |
| James Oliviero | Director | Fort Lee, NJ |
| Uri Ben-Or | Executive Officer | Fort Lee, NJ |
| Ron Bentsur | Executive Officer | Fort Lee, NJ |
| Enrique Poradosu | Executive Officer | Fort Lee, NJ |
| Shay Shemesh | Executive Officer | Fort Lee, NJ |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-07-19](https://search.stillhousedata.com/formd/0001859637-21-000001) | D | $11.3M | $11.3M |

## More

- [CIK 1859637 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1859637&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-21-131756.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.